醫療季淨利分析

最後更新 2026-03-25 08:40:09 (UTC+8)

醫療季淨利趨勢分析

判斷醫療類股公司整體季節調整後季淨利成長趨勢，包括季淨利季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療類股調整後季淨利與 XLV ETF走勢圖

FindBillion.com

季節調整後季淨利成長率


季淨利季增率	-11.1%
季淨利年增率	-9.8%

醫療季淨利與股價相關性分析

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季淨利有無相關性，若中高度相關性，可由整體季節調整後季淨利推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療類股整體季節調整後季淨利-股價散佈圖

醫療類股整體季節調整後季淨利與股價低度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季淨利與股價間的
決定係數

低度相關 0.09

FindBillion.com

醫療相關個股

醫療相關個股列表，包括各概念股的季淨利季增率、年增率等指標，協助評估概念股投資價值。

代碼	公司名稱	季淨利季增率	季淨利年增率
MASI	Masimo Corporation	轉虧為盈	轉虧為盈
NTRA	Natera, Inc.	轉虧為盈	轉虧為盈
CVS	CVS Health Corporation	轉虧為盈	79%
COR	Cencora, Inc.	轉虧為盈	14.5%
ARWR	Arrowhead Pharmaceuticals, Inc.	轉虧為盈	轉虧為盈
TAK	Takeda Pharmaceutical Company Limited	轉虧為盈	343.5%
ABBV	AbbVie Inc.	2015.8%	轉虧為盈
ARGX	argenx SE	427.9%	857.1%
ILMN	Illumina, Inc.	200.8%	78.6%
ALGN	Align Technology, Inc.	180.1%	30.8%
PHG	Koninklijke Philips N.V.	136.3%	轉虧為盈
UTHR	United Therapeutics Corporation	96.5%	20.9%
RVTY	Revvity, Inc.	89.3%	3.5%
DVA	DaVita Inc.	59.6%	-9.7%
JNJ	Johnson & Johnson	59.5%	49.1%
NVO	Novo Nordisk A/S	49.1%	-5.6%
HSIC	Henry Schein, Inc.	49%	7.4%
TEVA	Teva Pharmaceutical Industries Limited	35.4%	轉虧為盈
MEDP	Medpace Holdings, Inc.	32.2%	15.5%
ISRG	Intuitive Surgical, Inc.	30.4%	15.9%
IQV	IQVIA Holdings Inc.	30%	17.6%
GMED	Globus Medical, Inc.	28.5%	430.6%
ONC	BeOne Medicines Ltd.	27.8%	轉虧為盈
FMS	Fresenius Medical Care AG & Co. KGaA	27.6%	388.7%
EHC	Encompass Health Corporation	24.8%	20.8%
WAT	Waters Corporation	23.7%	-2.7%
COO	The Cooper Companies, Inc.	23.3%	25.4%
RMD	ResMed Inc.	22%	13.9%
WST	West Pharmaceutical Services, Inc.	20.1%	1.5%
ENSG	The Ensign Group, Inc.	19.1%	19.8%
DGX	Quest Diagnostics Incorporated	14.4%	10.4%
ZTS	Zoetis Inc.	14.3%	3.8%
MTD	Mettler-Toledo International Inc.	13%	13.3%
TMO	Thermo Fisher Scientific Inc.	12.2%	7.9%
MRK	Merck & Co., Inc.	11.4%	-20.8%
ALNY	Alnylam Pharmaceuticals, Inc.	11.4%	轉虧為盈
BMY	Bristol-Myers Squibb Company	7.3%	1408.3%
DXCM	DexCom, Inc.	6.7%	76.2%
SNN	Smith & Nephew plc	5.6%	263.5%
IDXX	IDEXX Laboratories, Inc.	5.1%	14.8%
VEEV	Veeva Systems Inc.	4.1%	24.8%
DHR	Danaher Corporation	-2.2%	10.2%
UHS	Universal Health Services, Inc.	-4.1%	34.2%
HLN	Haleon plc	-4.9%	76.4%
KRYS	Krystal Biotech, Inc.	-10.7%	13%
SYK	Stryker Corporation	-11.1%	55.5%
INCY	Incyte Corporation	-11.3%	48.7%
GILD	Gilead Sciences, Inc.	-12.2%	22.4%
STE	STERIS plc	-13.9%	11.1%
QGEN	Qiagen N.V.	-14.2%	22.1%
GSK	GSK plc	-14.5%	53.6%
LLY	Eli Lilly and Company	-15.3%	50.5%
HCA	HCA Healthcare, Inc.	-16.4%	30.6%
BSX	Boston Scientific Corporation	-16.6%	18%
THC	Tenet Healthcare Corporation	-17.5%	16.7%
ABT	Abbott Laboratories	-19.2%	-80.8%
MCK	McKesson Corporation	-19.6%	34.9%
CI	Cigna Corporation	-19.7%	-13.3%
EXEL	Exelixis, Inc.	-21.9%	74.8%
MDT	Medtronic plc	-23.4%	-11.7%
TECH	Bio-Techne Corporation	-23.6%	8.9%
A	Agilent Technologies, Inc.	-23.6%	-4.1%
AZN	AstraZeneca PLC	-24.9%	55.1%
PODD	Insulet Corporation	-26.4%	0.9%
LH	Labcorp Holdings Inc.	-27.8%	14.9%
CAH	Cardinal Health, Inc.	-28%	17.8%
JAZZ	Jazz Pharmaceuticals plc	-28.4%	6.5%
ZBH	Zimmer Biomet Holdings, Inc.	-29.5%	-41.8%
AMGN	Amgen Inc.	-34.1%	112.6%
VRTX	Vertex Pharmaceuticals Incorporated	-34.4%	30.5%
RPRX	Royalty Pharma plc	-34.4%	2.9%
ELV	Elevance Health Inc.	-36.9%	30.9%
ATR	AptarGroup, Inc.	-37.6%	-26.4%
REGN	Regeneron Pharmaceuticals, Inc.	-40.1%	-8%
ALC	Alcon Inc.	-43.9%	-23.6%
PEN	Penumbra, Inc.	-44.7%	40.6%
NBIX	Neurocrine Biosciences, Inc.	-45.8%	49.1%
EW	Edwards Lifesciences Corporation	-46.6%	-76.3%
RDY	Dr. Reddy's Laboratories Limited	-46.9%	-14.4%
NVS	Novartis AG	-54.3%	-14.5%
HOLX	Hologic, Inc.	-56.3%	-10.9%
BDX	Becton, Dickinson and Company	-58.7%	26.1%
GEHC	GE HealthCare Technologies Inc.	-66%	-74.4%
GMAB	Genmab A/S	-70.1%	-94.9%
SOLV	Solventum Corporation	-84.7%	103.2%
ICLR	ICON Public Limited Company	-98.8%	-98.8%
UNH	UnitedHealth Group Incorporated	-99.5%	-99.8%
PFE	Pfizer Inc.	-100%	-100%
BTSG	BrightSpring Health Services, Inc. Common Stock	-100%	381.8%
HALO	Halozyme Therapeutics, Inc.	-100%	-100%
MOH	Molina Healthcare, Inc.	-100%	-100%
HUM	Humana Inc.	-100%	-
SNY	Sanofi	-100%	-100%
BIIB	Biogen Inc.	-100%	-100%
CRL	Charles River Laboratories International, Inc.	-100%	-
ABVX	Abivax S.A.	-	-
CYTK	Cytokinetics, Incorporated	-	-
BNTX	BioNTech SE	-	-100%
TEM	Tempus AI, Inc.	-	-
EXAS	Exact Sciences Corporation	-	-
VTRS	Viatris Inc.	-	-
CNC	Centene Corporation	-	-100%
ELAN	Elanco Animal Health Incorporated	-	-
BAX	Baxter International Inc.	-	-
IONS	Ionis Pharmaceuticals, Inc.	-	-
BMRN	BioMarin Pharmaceutical Inc.	-	-100%
INSM	Insmed Incorporated	-	-
IBRX	ImmunityBio, Inc.	-	-
MDGL	Madrigal Pharmaceuticals, Inc.	-	-
MRNA	Moderna, Inc.	-	-
BBIO	BridgeBio Pharma, Inc.	-	-
GH	Guardant Health, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
AXSM	Axsome Therapeutics, Inc.	-	-
RGC	Regencell Bioscience Holdings Limited	-	-
ROIV	Roivant Sciences Ltd.	-	-100%
RVMD	Revolution Medicines, Inc.	-	-
ASND	Ascendis Pharma A/S	-	-
SMMT	Summit Therapeutics Inc.	-	-
MDLN	Medline Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股

醫療季淨利趨勢分析

判斷 醫療 類股公司整體季節調整後季淨利成長趨勢，包括季淨利季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療季淨利與股價相關性分析

判斷 醫療 類股ETF(XLV) 股價和類股整體季節調整後季淨利有無相關性，若中高度相關性，可由整體季節調整後季淨利推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股

醫療 相關個股列表，包括各概念股的季淨利季增率、年增率等指標，協助評估概念股投資價值。

判斷醫療類股公司整體季節調整後季淨利成長趨勢，包括季淨利季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季淨利有無相關性，若中高度相關性，可由整體季節調整後季淨利推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股列表，包括各概念股的季淨利季增率、年增率等指標，協助評估概念股投資價值。